n.a. (ZMH)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Shares Outstanding 170.40M
Div & Yield N.A. (N.A)

Zimmer Beats, Guides Lower

Sales rise 4%.

Blue Chips Still Running

Blue Chips Still Running

Early strength survives a huge reading on durable goods.

Futures Show Signs of Life

Futures Show Signs of Life

Solid quarters at Amazon, WellPoint and Sanmina buoy sentiment.

Solid Numbers at Stryker

Investors breathe a sigh of relief.

Health Care Cuts Create Opportunity

Health Care Cuts Create Opportunity

Selling on the news of reimbursement cuts has historically created profit.

Forget Fountains, Grab a Basket of Youth

Forget Fountains, Grab a Basket of Youth

Play the fight against aging with two reasonably valued companies in this overheated sector.

Forget Fountains, Grab a Basket of Youth

Play the fight against aging with two reasonably valued companies in this overheated sector.

Could Implant Makers Lose Their Crutch?

Medicare has fostered a dream market for orthopedic implant makers, but reforms could end that.

Biomet Plays Mating Game

Biomet Plays Mating Game

Analysts see many possible partners but wonder about the price.

Biomet on the Block: Report

Biomet on the Block: Report

CNBC says the company hires Morgan Stanley.

Biomet Backer on Selling Spree

Biomet Backer on Selling Spree

Ex-CEO Dane Miller undercuts takeover talk by selling stock.

Joint Makers Feel Pain

Joint Makers Feel Pain

A downgrade hammers Zimmer and Stryker, while Biomet makes a change at the top.

Joint Makers Feel the Pain

Joint Makers Feel the Pain

A downgrade hammers Zimmer and Stryker, while Biomet makes a change at the top.

The Five Dumbest Things on Wall Street This Week

The Five Dumbest Things on Wall Street This Week

Cloudy Vista; Verizon greens fees; GM numbers game; joint chiefs; Sovereign rulers.

Creaky Quarter at Biomet

Creaky Quarter at Biomet

The stock falls as the top line comes in short.

Today's Health Winners and Losers

Today's Health Winners and Losers

NMT Medical shares tumble after a trial of its migraine treatment doesn't meet its endpoint.

The Five Dumbest Things on Wall Street This Week

The Five Dumbest Things on Wall Street This Week

HCA cornered; Motorola muscle; Vonage voyage; Parsons project; Byrne unit.

The Real Story: 3 Cheers for Encore Medical

The Real Story: 3 Cheers for Encore Medical

Management appears to be making the right decisions to grow the business and pay down debt.

Zimmer, HCA Clash Over Discounts

A joint implant-pricing deal isn't going smoothly.

Zimmer Ices Slowdown Talk

Zimmer Ices Slowdown Talk

But some still wonder about the 'hockey stick' look of its forecasts.

HCA Makes Discount Headway

The company says it is holding the line on orthopedic joint contracts.

Growth on Simmer at Zimmer

The onetime highflier has slowed a bit but still bests estimates.

Fed Jitters Freeze Stocks

Fed Jitters Freeze Stocks

The averages close narrowly mixed ahead of the FOMC meeting.

Stocks Bide Time After Rally

Stocks Bide Time After Rally

Sales guidance from Wal-Mart could provide a boost.

Stryker Strikes Back

Stryker Strikes Back

A solid quarter ignites a sharp sectorwide rally.

Stryker Hip to Challenges

Stryker Hip to Challenges

The latest numbers mostly placate growth-questioning investors.

Iron Is Hot at Stryker

Iron Is Hot at Stryker

Investors want news on a price standoff with HCA.

Cramer's 'Mad Money Lightning Round': Capital Punishment

Cramer's 'Mad Money Lightning Round': Capital Punishment

Cramer goes into a bar, and a short learns a lesson on Capital One Financial.

Biomet Comes Up Short

Biomet Comes Up Short

The company misses estimates and offers guidance that fails to meet with Wall Street's approval.

Will Biomet Bend?

Will Biomet Bend?

Investors will parse earnings for a read on HCA's efforts to browbeat joint-implant suppliers.